| Item Type | Name |
|
Academic Article
|
Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
|
|
Academic Article
|
Aspirin and angiotensin-converting enzyme inhibitors are safe when taken together after acute myocardial infarction in patients with left ventricular dysfunction.
|
|
Academic Article
|
Halting the progression of heart failure: finding the optimal combination therapy.
|
|
Academic Article
|
American Society of Hypertension regional chapters: leveraging the impact of the clinical hypertension specialist in the local community.
|
|
Academic Article
|
Systolic blood pressure elevation: it's where the action is.
|
|
Academic Article
|
Controlling blood pressure in 50% of all hypertensive patients: an achievable goal in the healthy people 2010 report?
|
|
Academic Article
|
Analysis of recent papers in hypertension.
|
|
Academic Article
|
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study.
|
|
Academic Article
|
Hypertension and heart failure. Roundtable discussion.
|
|
Academic Article
|
Combination agents as a means of improving adherence and other aspects of the sixth Joint National Committee Report.
|
|
Academic Article
|
Cardioprotection: the role of beta-blocker therapy.
|
|
Academic Article
|
A trial of education, prompts, and opinion leaders to improve prescription of lipid modifying therapy by primary care physicians for patients with ischemic heart disease.
|
|
Academic Article
|
Excessive alcohol consumption and hypertension: clinical implications of current research.
|
|
Academic Article
|
Cardiovascular risk factor control in communities--update from the ASH Carolinas-Georgia Chapter, the Hypertension Initiative, and the Community Physicians' Network.
|
|
Academic Article
|
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
|
|
Academic Article
|
Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
|
|
Academic Article
|
Shifting paradigms in defining and treating hypertension: addressing global risk with combination therapy.
|
|
Academic Article
|
Thresholds for diastolic blood pressure reduction in older patients with isolated systolic hypertension appear to be different depending on the presence or absence of underlying coronary heart disease.
|
|
Academic Article
|
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
|
|
Academic Article
|
Self measurement of blood pressure at home should complement rather than replace office blood pressure management.
|
|
Academic Article
|
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
|
|
Academic Article
|
Rationale for fixed-dose combination therapy to reach lower blood pressure goals.
|
|
Academic Article
|
Analysis of recent papers in hypertension.
|
|
Academic Article
|
Analysis of recent papers in hypertension. Lack of legacy effect with more intensive blood pressure control in the long-term follow-up of the United Kingdom Prospective Diabetes Study.
|
|
Academic Article
|
Antihypertensive therapy, new-onset diabetes, and cardiovascular disease.
|
|
Academic Article
|
Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension.
|
|
Academic Article
|
Heart failure in people younger than 50 years is more common in black than white Americans and is closely associated with poorly treated and controlled hypertension: the CARDIA study.
|
|
Academic Article
|
Beta-blockers for treatment of hypertension.
|
|
Academic Article
|
Beta-blockers for preventing sudden cardiac death.
|
|
Academic Article
|
Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy.
|
|
Academic Article
|
Combination therapy in hypertension.
|
|
Academic Article
|
High adherence to antihypertensive therapy is rare but when present is associated with a decreased risk of cardiovascular events.
|
|
Academic Article
|
Angiotensin receptor blocker use may decrease the incidence and progression of Alzheimer's disease and dementia in older men but the strength of the evidence is questionable.
|
|
Academic Article
|
Meta-analysis concludes angiotensin receptor blocker use increases the risk of developing cancer: concerns about the science and the message.
|
|
Academic Article
|
Combination angiotensin receptor blocker-neutral endopeptidase inhibitor provides additive blood pressure reduction over angiotensin receptor blocker alone.
|
|
Academic Article
|
Comparison of aliskiren/hydrochlorothiazide combination therapy with hydrochlorothiazide monotherapy in older patients with stage 2 systolic hypertension: results of the ACTION study.
|
|
Academic Article
|
Catheter-based renal sympathetic nerve ablation controls blood pressure in more difficult-to-control patients taking multi-agent pharmacologic therapy.
|
|
Academic Article
|
Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals.
|
|
Academic Article
|
Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
|
|
Academic Article
|
Analysis of recent papers in hypertension: nighttime administration of at least one antihypertensive medication is associated with better blood pressure control and cardiovascular outcomes in patients with type 2 diabetes or chronic kidney disease.
|
|
Academic Article
|
The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM).
|
|
Academic Article
|
Titration of beta-blockers in heart failure. How to maximize benefit while minimizing adverse events.
|
|
Academic Article
|
Determining the relative antihypertensive potency and relative cardiovascular risk reduction associated with different thiazide and thiazide-type diuretics.
|
|
Academic Article
|
Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHAT.
|
|
Academic Article
|
Analysis of recent papers in hypertension. Initial combination therapy provides more prompt blood pressure control and reduces cardiovascular events but remains underutilized.
|
|
Academic Article
|
Analysis of recent papers in hypertension. Need for more aggressive blood pressure control in diabetes.
|
|
Academic Article
|
Stability of basal metabolic rate over selected days of the menstrual cycle.
|
|
Academic Article
|
A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension.
|
|
Academic Article
|
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
|
|
Academic Article
|
Management of global risk across the continuum of hypertensive heart disease.
|
|
Academic Article
|
A historical look at hypertension: celebrating 100 years with the Southern Medical Association.
|
|
Academic Article
|
Fixed-dose combination therapy in the treatment of hypertension: ready for prime time.
|
|
Academic Article
|
Recognizing the link between CKD and CVD in the primary care setting: accurate and early diagnosis for timely and appropriate intervention.
|
|
Academic Article
|
Analysis of recent papers in hypertension.
|
|
Academic Article
|
Clinical considerations and practical recommendations for the primary care practitioner in the management of anemia of chronic kidney disease.
|
|
Academic Article
|
Analysis of recent papers in hypertension: a simple office-based tool to predict the development of hypertension.
|
|
Academic Article
|
Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
|
|
Academic Article
|
All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective.
|
|
Academic Article
|
In angiotensin-converting enzyme inhibitor-intolerant individuals, the angiotensin receptor blocker telmisartan does not reduce the incidence of major cardiovascular events in high-risk patients: lessons learned from the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects Wtih Cardiovascular Disease (TRANSCEND).
|
|
Academic Article
|
Analysis of recent papers in hypertension.
|
|
Academic Article
|
Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial.
|
|
Academic Article
|
Lessons learned from the ONTARGET and TRANSCEND trials.
|
|
Academic Article
|
Prior incarceration is associated with an increased risk for developing hypertension.
|
|
Academic Article
|
Does prehypertension represent an increased risk for incident hypertension and adverse cardiovascular outcome?
|
|
Academic Article
|
Largest meta-analysis to date suggests that patients at risk for cardiovascular disease events derive benefit from antihypertensive therapy regardless of baseline blood pressure and to reduce vascular events, lowering blood pressure is more important than choice of antihypertensive drug class.
|
|
Academic Article
|
A lower blood pressure goal in patients without diabetes lessens the occurrence of left ventricular hypertrophy.
|
|
Academic Article
|
Identifying and managing factors that interfere with or worsen blood pressure control.
|
|
Academic Article
|
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
|
|
Academic Article
|
Is there accord in ACCORD? Lower blood pressure targets in type 2 diabetes does not lead to fewer cardiovascular events except for reductions in stroke.
|
|
Academic Article
|
Intensive blood pressure control in children slows progression of chronic kidney disease.
|
|
Academic Article
|
Review of recent literature: Existing kidney disease classification guideline needs to incorporate degree of proteinuria with estimated glomerular filtration rate to more accurately predict cardiovascular and renal risk.
|
|
Academic Article
|
In navigator, the angiotensin receptor blocker valsartin modestly reduced the progression to type 2 diabetes but had no effect on cardiovascular events in higher-risk patients with impaired glucose tolerance.
|
|
Academic Article
|
Treating the black hypertensive in 2010: achieve lower targets while awaiting more definitive evidence.
|
|
Academic Article
|
Highly interactive multi-session programs impact physician behavior on hypertension management: outcomes of a new CME model.
|
|
Academic Article
|
Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in?patients with dyslipidemia: The SUPREME Study.
|
|
Academic Article
|
A new approach to glucose control in type 2 diabetes: the role of kidney sodium-glucose co-transporter 2 inhibition.
|
|
Academic Article
|
Spironolactone is more effective than eplerenone at lowering blood pressure in patients with primary aldosteronism.
|
|
Academic Article
|
New British guidelines mandate ambulatory blood pressure monitoring to diagnose hypertension in all patients: not ready for prime time in the United States.
|
|
Academic Article
|
UK guidelines call for routine 24-hour ambulatory blood pressure monitoring in all patients to make the diagnosis of hypertension--not ready for prime time in the United States.
|
|
Academic Article
|
The Rheos Pivotol trial evaluating baroreflex activation therapy fails to meet efficacy and safety end points in resistant hypertension: back to the drawing board.
|
|
Academic Article
|
Exposure to air pollution increases the incidence of hypertension and diabetes in black women living in Los Angeles.
|
|
Academic Article
|
Analysis of recent papers in hypertension: Treatment of obstructive sleep apnea with continuous positive airway pressure appears to decrease the incidence of incident hypertension.
|
|
Academic Article
|
Increased calcium intake does not suppress circulating 1,25-dihydroxyvitamin D in normocalcemic patients with sarcoidosis.
|
|
Concept
|
Body Mass Index
|
|
Concept
|
Diet, Sodium-Restricted
|
|
Concept
|
Primary Health Care
|
|
Concept
|
Age Factors
|
|
Concept
|
Myocardial Ischemia
|
|
Concept
|
Hyperglycemia
|
|
Concept
|
Drug Administration Schedule
|
|
Concept
|
Calcium Channel Blockers
|
|
Concept
|
Prognosis
|
|
Concept
|
Calcium, Dietary
|
|
Concept
|
Health Education
|
|
Concept
|
Patient Selection
|
|
Concept
|
Dipeptidyl-Peptidase IV Inhibitors
|
|
Concept
|
Health Services Accessibility
|
|
Concept
|
Education, Medical, Continuing
|
|
Concept
|
Guidelines as Topic
|
|
Concept
|
Data Interpretation, Statistical
|
|
Concept
|
Blood Pressure
|
|
Concept
|
Health Status Indicators
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
Community Networks
|
|
Concept
|
Lupus Nephritis
|
|
Concept
|
Amlodipine
|
|
Concept
|
Aged, 80 and over
|
|
Concept
|
Pain
|
|
Concept
|
Incidence
|
|
Concept
|
Verapamil
|
|
Concept
|
Proportional Hazards Models
|
|
Concept
|
Erythropoietin
|
|
Concept
|
Drugs, Investigational
|
|
Concept
|
Cardiac Output, Low
|
|
Concept
|
Membrane Transport Modulators
|
|
Concept
|
Sex Distribution
|
|
Concept
|
Nitrendipine
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Drug Costs
|
|
Concept
|
Diabetes Complications
|
|
Concept
|
Nitric Oxide
|
|
Concept
|
Sampling Studies
|
|
Concept
|
Canada
|
|
Concept
|
Hypertension
|
|
Concept
|
Practice Guidelines as Topic
|
|
Concept
|
Public Health Practice
|
|
Concept
|
Disease Progression
|
|
Concept
|
Hypoglycemic Agents
|
|
Concept
|
Kidney Diseases
|
|
Concept
|
Death, Sudden, Cardiac
|
|
Concept
|
Alcohol Drinking
|
|
Concept
|
Endothelium, Vascular
|
|
Concept
|
Health Knowledge, Attitudes, Practice
|
|
Concept
|
Benzimidazoles
|
|
Concept
|
North Carolina
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
History, 21st Century
|
|
Concept
|
Kidney Failure, Chronic
|
|
Concept
|
Controlled Clinical Trials as Topic
|
|
Concept
|
History, 19th Century
|
|
Concept
|
Dihydroxycholecalciferols
|
|
Concept
|
Potassium
|
|
Concept
|
China
|
|
Concept
|
Research Design
|
|
Concept
|
Combined Modality Therapy
|
|
Concept
|
Animals
|
|
Concept
|
Georgia
|
|
Concept
|
Aged
|
|
Concept
|
Homeostasis
|
|
Concept
|
Database Management Systems
|
|
Concept
|
Chronic Disease
|
|
Concept
|
Adrenergic beta-Antagonists
|
|
Concept
|
Societies, Medical
|
|
Concept
|
Double-Blind Method
|
|
Concept
|
Algorithms
|
|
Concept
|
Reminder Systems
|
|
Concept
|
Patient Education as Topic
|
|
Concept
|
Vasodilator Agents
|
|
Concept
|
Ramipril
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Drug Evaluation
|
|
Concept
|
Cholesterol, LDL
|
|
Concept
|
Medical Records
|
|
Concept
|
Coronary Artery Disease
|
|
Concept
|
Aspirin
|
|
Concept
|
Stroke
|
|
Concept
|
Sample Size
|
|
Concept
|
Mortality
|
|
Concept
|
Calcium
|
|
Concept
|
Health Promotion
|
|
Concept
|
Recombinant Proteins
|
|
Concept
|
Central Nervous System Depressants
|
|
Concept
|
Angioedema
|
|
Concept
|
Guideline Adherence
|
|
Concept
|
Heart Failure
|
|
Concept
|
Myocardial Infarction
|
|
Concept
|
Diabetes Mellitus
|
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
|
Concept
|
Thiophenes
|
|
Concept
|
Renin-Angiotensin System
|
|
Concept
|
Hypertension, Renal
|
|
Concept
|
Drug Interactions
|
|
Concept
|
Hydrochlorothiazide
|
|
Concept
|
Diabetic Nephropathies
|
|
Concept
|
Aminobutyrates
|
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
|
Concept
|
Biopsy
|
|
Concept
|
Amides
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Dietary Supplements
|
|
Concept
|
Early Diagnosis
|
|
Concept
|
Obesity
|
|
Concept
|
Logistic Models
|
|
Concept
|
Anemia
|
|
Concept
|
Lisinopril
|
|
Concept
|
Cardiovascular Agents
|
|
Concept
|
Glucosides
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Sodium
|
|
Concept
|
Neprilysin
|
|
Concept
|
Cardiovascular Diseases
|
|
Concept
|
Physicians, Family
|
|
Concept
|
Lipids
|
|
Concept
|
Sympathetic Nervous System
|
|
Concept
|
Hypertrophy, Left Ventricular
|
|
Concept
|
Angiotensin II Type 1 Receptor Blockers
|
|
Concept
|
Renin
|
|
Concept
|
Antihypertensive Agents
|
|
Concept
|
Chlorthalidone
|
|
Concept
|
Mandatory Testing
|
|
Concept
|
Cerebral Hemorrhage
|
|
Concept
|
Diabetes Mellitus, Type 2
|
|
Concept
|
Basal Metabolism
|
|
Concept
|
Treatment Failure
|
|
Concept
|
Adult
|
|
Concept
|
Drug Chronotherapy
|
|
Concept
|
Cholesterol, Dietary
|
|
Concept
|
Sarcoidosis
|
|
Concept
|
Health Policy
|
|
Concept
|
Male
|
|
Concept
|
Multicenter Studies as Topic
|
|
Concept
|
Nifedipine
|
|
Concept
|
Alcoholism
|
|
Concept
|
Quality of Life
|
|
Concept
|
Gastrointestinal Hemorrhage
|
|
Concept
|
Pravastatin
|
|
Concept
|
Heart Rate
|
|
Concept
|
Glomerular Filtration Rate
|
|
Concept
|
Proteinuria
|
|
Concept
|
Female
|
|
Concept
|
Biomedical Research
|
|
Concept
|
Ventricular Dysfunction, Left
|
|
Concept
|
Exercise
|
|
Concept
|
Drug Resistance
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
Time Factors
|
|
Concept
|
Survival Rate
|
|
Concept
|
Humans
|
|
Concept
|
Oxidative Stress
|
|
Concept
|
Gluconeogenesis
|
|
Concept
|
Vitamin D
|
|
Concept
|
Liver Diseases
|
|
Concept
|
Pyridines
|
|
Concept
|
Doxazosin
|
|
Concept
|
History, 20th Century
|
|
Concept
|
Adrenergic alpha-Antagonists
|
|
Concept
|
Cholesterol, HDL
|
|
Concept
|
Interprofessional Relations
|
|
Concept
|
Medication Adherence
|
|
Concept
|
American Heart Association
|
|
Concept
|
Ethanolamines
|
|
Concept
|
Erythropoiesis
|
|
Concept
|
Blood Glucose
|
|
Concept
|
Sympathectomy
|
|
Concept
|
Life Style
|
|
Concept
|
Data Collection
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Systole
|
|
Concept
|
Acute Coronary Syndrome
|
|
Concept
|
Benzopyrans
|
|
Concept
|
Uric Acid
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Feeding Behavior
|
|
Concept
|
Hypolipidemic Agents
|
|
Concept
|
Population Surveillance
|
|
Concept
|
Benzoates
|
|
Concept
|
Clinical Competence
|
|
Concept
|
Platelet Aggregation Inhibitors
|
|
Concept
|
Periodicals as Topic
|
|
Concept
|
Meta-Analysis as Topic
|
|
Concept
|
Cost-Benefit Analysis
|
|
Concept
|
Coronary Disease
|
|
Concept
|
Glycerophospholipids
|
|
Concept
|
Diuretics
|
|
Concept
|
South Carolina
|
|
Concept
|
Kidney
|
|
Concept
|
Hypokalemia
|
|
Concept
|
Angiotensin-Converting Enzyme Inhibitors
|
|
Concept
|
Pressoreceptors
|
|
Concept
|
Inpatients
|
|
Concept
|
American Medical Association
|
|
Concept
|
Prevalence
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Baroreflex
|
|
Concept
|
Patient Compliance
|
|
Concept
|
Albuminuria
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Menstrual Cycle
|
|
Concept
|
Health Status Disparities
|
|
Concept
|
Fumarates
|
|
Concept
|
Prospective Studies
|
|
Concept
|
United Kingdom
|
|
Concept
|
Ethanol
|
|
Concept
|
Hyperlipidemias
|
|
Concept
|
Digoxin
|
|
Concept
|
Biphenyl Compounds
|
|
Concept
|
Ferritins
|
|
Concept
|
Diet
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Evidence-Based Medicine
|
|
Concept
|
Cardiotonic Agents
|
|
Concept
|
Lipid Metabolism
|
|
Concept
|
Creatinine
|
|
Concept
|
Dyslipidemias
|
|
Concept
|
Surveys and Questionnaires
|
|
Concept
|
Hypotension, Orthostatic
|
|
Concept
|
Anticholesteremic Agents
|
|
Concept
|
Blood Pressure Monitoring, Ambulatory
|
|
Concept
|
Practice Patterns, Physicians'
|
|
Concept
|
Bendroflumethiazide
|
|
Concept
|
Middle Aged
|
|
Concept
|
Cardiovascular System
|
|
Concept
|
Peptidyl-Dipeptidase A
|
|
Concept
|
Blood Pressure Determination
|
|
Concept
|
United States
|
|
Concept
|
Southeastern United States
|
|
Concept
|
Lupus Erythematosus, Systemic
|
|
Concept
|
Diabetic Angiopathies
|
|
Concept
|
Hypercholesterolemia
|
|
Concept
|
Cholesterol
|
|
Concept
|
Neoplasms
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Metabolic Syndrome
|
|
Concept
|
Skin
|
|
Concept
|
Sodium-Glucose Transporter 2
|
|
Concept
|
Risk
|
|
Concept
|
Risk Factors
|
|
Concept
|
Thiazepines
|
|
Concept
|
Benzazepines
|
|
Concept
|
Benzhydryl Compounds
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Drug Prescriptions
|
|
Concept
|
Drug Combinations
|
|
Concept
|
Comorbidity
|
|
Concept
|
Renal Insufficiency, Chronic
|
|
Concept
|
Sodium Chloride Symporter Inhibitors
|
|
Concept
|
Congresses as Topic
|
|
Concept
|
Age Distribution
|
|
Concept
|
Tetrazoles
|
|
Academic Article
|
NHANES data highlight the clinical characteristics of those with poorly controlled hypertension.
|
|
Academic Article
|
Review of recent literature in hypertension: updated clinical practice guidelines for chronic kidney disease now include albuminuria in the classification system.
|
|
Academic Article
|
Analysis of recent papers in hypertension treatment of hypertension in the setting of acute intracerebral hemorrhage: still no clear answer on the best BP level to intervene or what BP goal to achieve.
|
|
Academic Article
|
Renal sympathetic denervation for blood pressure control: a review of the current evidence and ongoing studies.
|
|
Academic Article
|
Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT.
|
|
Academic Article
|
Recent clinical trials.
|
|
Academic Article
|
Ambulatory blood pressure monitoring to diagnose hypertension--an idea whose time has come.
|
|
Academic Article
|
A Multifactorial Approach to Reduce Cardiovascular Disease in Type 2 Diabetes Mellitus: Now More Than Ever.
|
|
Academic Article
|
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy.
|
|
Academic Article
|
Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance.
|
|
Academic Article
|
Analysis of Recent Papers in Hypertension.
|
|
Academic Article
|
The Importance of Systolic Blood Pressure Control and Cardiovascular Disease Prevention.
|
|
Academic Article
|
Hypertension and Its Complications in a Young Man With Autoimmune Disease.
|
|
Academic Article
|
Risk of Hospitalization for Cardiovascular Events with ?-Blockers in Hypertensive Patients: A Retrospective Cohort Study.
|
|
Academic Article
|
Uncontrolled Hypertension in an Elderly Man on Multiple Antihypertensive Drugs.
|
|
Academic Article
|
Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association.
|
|
Concept
|
Diabetic Cardiomyopathies
|
|
Concept
|
Peripheral Arterial Disease
|
|
Concept
|
Public Health Surveillance
|
|
Concept
|
Glucagon-Like Peptide-1 Receptor
|
|
Concept
|
Nebivolol
|
|
Concept
|
Valsartan
|
|
Concept
|
Canagliflozin
|
|
Concept
|
Angiotensin Receptor Antagonists
|
|
Academic Article
|
How We Got Where We Are in Blood Pressure Targets.
|